A multicenter, randomized, placebo‐controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis
OBJECTIVE:Rheumatoid arthritis (RA) is associated with increased cardiovascular event (CVE) risk. The impact of statins in RA is not established. We assessed whether atorvastatin is superior to placebo for the primary prevention of CVE in RA patients. METHODS:Randomized, double-blind, placebo-contro...
| Váldodahkkit: | , , , , , |
|---|---|
| Eará dahkkit: | |
| Materiálatiipa: | Journal article |
| Giella: | English |
| Almmustuhtton: |
Wiley Periodicals
2019
|